GlycoMimetics Inc (NASDAQ:GLYC)’s traded shares stood at 0.82 million during the last session, with the company’s beta value hitting 1.80. At the close of trading, the stock’s price was $0.24, to imply a decrease of -7.44% or -$0.02 in intraday trading. The GLYC share’s 52-week high remains $3.53, putting it -1370.83% down since that peak but still an impressive 41.67% since price per share fell to its 52-week low of $0.14. The company has a valuation of $15.24M, with an average of 0.72 million shares in intraday trading volume over the past 10 days and average of 19.97 million shares over the past 3 months.
Analysts have given a consensus recommendation of Hold for GlycoMimetics Inc (GLYC), translating to a mean rating of 3.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give GLYC a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 0 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GlycoMimetics Inc (NASDAQ:GLYC) trade information
After registering a -7.44% downside in the last session, GlycoMimetics Inc (GLYC) has traded red over the past five days. The 5-day price performance for the stock is 15.04%, and -26.36% over 30 days. With these gigs, the year-to-date price performance is -89.98%. Short interest in GlycoMimetics Inc (NASDAQ:GLYC) saw shorts transact 5.64 million shares and set a 1.07 days time to cover.
GLYC Dividends
GlycoMimetics Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
GlycoMimetics Inc (NASDAQ:GLYC)’s Major holders
GlycoMimetics Inc insiders hold 3.12% of total outstanding shares, with institutional holders owning 47.91% of the shares at 49.46% float percentage. In total, 47.91% institutions holds shares in the company, led by BVF INC/IL. As of 2024-06-30, the company held over 9.54 million shares (or 14.8071% of shares), all amounting to roughly $2.69 million.
The next major institution holding the largest number of shares is ARTAL GROUP S.A. with 8.59 million shares, or about 13.3252% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $2.42 million.
We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the GlycoMimetics Inc (GLYC) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 1.93 shares. This is just over 2.99% of the total shares, with a market valuation of $0.46 million. Data from the same date shows that the other fund manager holds a little less at 730.6, or 1.13% of the shares, all valued at about 0.17 million.
